Analysis of Polymer/siRNA Nanoparticle Efficacy and Biocompatibility in 3D Air-Liquid Interface Culture Compared to 2D Cell Culture

被引:0
作者
Noske, Sandra [1 ]
Krueger, Martin [2 ]
Ewe, Alexander [1 ]
Aigner, Achim [1 ]
机构
[1] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Fac Med, Clin Pharmacol, D-04107 Leipzig, Germany
[2] Univ Leipzig, Inst Anat, Liebigstr 13, D-04103 Leipzig, Germany
关键词
polyethylenimine; PEI; tyrosine-modified PEI; fluoroalkyl-PEI; air-liquid interface culture; gene knockdown; RNAi; LIPOSOME-POLYETHYLENIMINE COMPLEXES; MOLECULAR-WEIGHT POLYETHYLENIMINE; PULMONARY DRUG-DELIVERY; IN-VITRO MODEL; SIRNA DELIVERY; LUNG-DISEASE; RPMI; 2650; DNA; LIPOPOLYPLEXES; OPTIMIZATION;
D O I
10.3390/pharmaceutics17030339
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Polymeric nanoparticles have been explored as efficient tools for siRNA delivery to induce RNAi-mediated gene knockdown. Chemical modifications of polyethylenimines (PEI) enhance nanoparticle efficacy and biocompatibility. Their in vivo use, however, benefits from prior analyses in relevant in vitro 3D conditions. Methods: We utilize a 3D ALI cell culture model for testing the biological activities and toxicities of a set of different PEI-based nanoparticles with different chemical modifications. This also includes a novel, fluoroalkyl-modified PEI. Reporter gene knockdown is directly compared to 2D cell culture. In parallel, biocompatibility is assessed by measuring cell viability and lactate dehydrogenase (LDH) release. Results: Knockdown efficacies in the 3D ALI model are dependent on the chemical modification and complex preparation conditions. Results only correlate in part with gene knockdown in 2D cell culture, identifying nanoparticle penetration and cellular internalization under 3D conditions as important parameters. The 3D ALI cell culture is also suitable for the quantitative determination of nanoparticle effects on cell viability and acute toxicity, with biocompatibility benefitting from PEI modifications. Conclusions: The 3D ALI cell model allows for a more realistic assessment of biological nanoparticle effects. A novel fluoroalkyl-modified PEI is described. Optimal preparations of PEI-based nanoparticles for siRNA delivery and gene knockdown are identified.
引用
收藏
页数:22
相关论文
共 76 条
  • [1] In vitro Cell Culture Model for Toxic Inhaled Chemical Testing
    Ahmad, Shama
    Ahmad, Aftab
    Neeves, Keith B.
    Hendry-Hofer, Tara
    Loader, Joan E.
    White, Carl W.
    Veress, Livia
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (87):
  • [2] The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials
    Alsaeedi, A
    Sin, DD
    McAlister, FA
    [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 113 (01) : 59 - 65
  • [3] A new computer-controlled air-liquid interface cultivation system for the generation of differentiated cell cultures of the airway epithelium
    Aufderheide, Michaela
    Foerster, Christine
    Beschay, Morris
    Branscheid, Detlev
    Emura, Makito
    [J]. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2016, 68 (01) : 77 - 87
  • [4] Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
    Baldassi, Domizia
    Ngo, Thi My Hanh
    Merkel, Olivia M.
    [J]. PHARMACEUTICAL RESEARCH, 2024, 41 (01) : 77 - 91
  • [5] Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes
    Baldassi, Domizia
    Ambike, Shubhankar
    Feuerherd, Martin
    Cheng, Cho-Chin
    Peeler, David J.
    Feldmann, Daniel P.
    Porras-Gonzalez, Diana Leidy
    Wei, Xin
    Keller, Lea-Adriana
    Kneidinger, Nikolaus
    Stoleriu, Mircea Gabriel
    Popp, Andreas
    Burgstaller, Gerald
    Pun, Suzie H.
    Michler, Thomas
    Merkel, Olivia M.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2022, 345 : 661 - 674
  • [6] Air-Liquid Interface Cultures of the Healthy and Diseased Human Respiratory Tract: Promises, Challenges, and Future Directions
    Baldassi, Domizia
    Gabold, Bettina
    Merkel, Olivia M.
    [J]. ADVANCED NANOBIOMED RESEARCH, 2021, 1 (06):
  • [7] Gene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?
    Banuls, Lucia
    Pellicer, Daniel
    Castillo, Silvia
    Mercedes Navarro-Garcia, Maria
    Magallon, Maria
    Gonzalez, Cruz
    Dasi, Francisco
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 29
  • [8] Characterization of critical parameters using an air-liquid interface model with RPMI 2650 cells for permeability studies of small molecules
    Barlang, Lea-Adriana
    Weinbender, Kristina
    Merkel, Olivia M.
    Popp, Andreas
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2024, 14 (06) : 1601 - 1615
  • [9] Inter-laboratory variability of A549 epithelial cells grown under submerged and air-liquid interface conditions
    Barosova, Hana
    Meldrum, Kirsty
    Karakocak, Bedia Begum
    Balog, Sandor
    Doak, Shareen H.
    Petri-Fink, Alke
    Clift, Martin J. D.
    Rothen-Rutishauser, Barbara
    [J]. TOXICOLOGY IN VITRO, 2021, 75
  • [10] Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture
    Barron, Sarah L.
    Wyatt, Owen
    O'Connor, Andy
    Mansfield, David
    Cohen, E. Suzanne
    Witkos, Tomasz M.
    Strickson, Sam
    Owens, Roisin M.
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)